ARCHIVES

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

MacFarlane, Frelick to Speak At Seminar

July 22, 1983

ACOS Planning Patient Care Melanoma Study

August 4, 1989

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

March 5, 1993

In Belief: Warren Ross Named Director Of Louisville’s Brown Cancer Center; NCI Landow Offices Moved

August 5, 1988

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

November 28, 1986

New Year Sees Growing Attacks On Cancer Program; Critics Repeat Untrue Charges, OMB Continues

January 3, 1975